Strains producing Stx2a+, particularly those belonging to lineage Ic (PT21/28), are known to be associated with severe clinical outcomes, such as HUS [5] and sub-lineage IIb PT8 strains cause more severe disease when stx2a replaces stx2c [9]. Here, STX2 is linked to hemolytic-uremic syndrome.